| 潘广鹏 王义海 张瑾 曾敏 吕茵 卢喜.Rapid arc 联合呼吸门控在非小细胞肺癌放疗中的应用[J].,2014,14(23):4475-4478 |
| Rapid arc 联合呼吸门控在非小细胞肺癌放疗中的应用 |
| Application of Rapid Arc Combined Respiratory Gating in the Radiotherapyof Non-small Cell Lung Cancer |
| |
| DOI： |
| 中文关键词: 非小细胞肺癌 Rapid arc 呼吸门控 |
| 英文关键词: Non-small cell lung cancer Rapid arc Respiratory gating |
| 基金项目:新疆维吾尔自治区科技支疆项目（201191159） |
|
| 摘要点击次数: 861 |
| 全文下载次数: 1101 |
| 中文摘要: |
| 目的：探讨RapidArc 联合呼吸门控技术在非小细胞肺癌放射治疗中的应用。方法：选取未能手术的ⅢA-ⅢB 期非小细胞肺
癌患者19 例，分别在自由呼吸(FB) 和呼吸门控系统RC 状态下为每例患者设计FB 下的IMRT (IMRT-FB)、双弧RapidArc
(Arc-FB)和RC 下的IMRT(IMRT-RC)、双弧RapidArc(Arc-RC)4种放疗计划。评价四种计划和Arc-RC 治疗的疗效及副反应。结
果：除1 例患者由于经济原因中途退出，其他患者均顺利完成治疗。PTV 的平均体积由FB 下的296 cm3减少到了RC 下的210.2
cm3；RC下的双肺平均体积为3817.4 cm3，较FB 增加了34%；Arc-RC计划靶区的CI、HI及D2%、D98%、V95，与IMRT-FB、Arc-FB、
IMRT-RC 计划差异无统计学意义，但双肺的V20、V30、V40、V50、及平均剂量(Dmean)明显低于后三者(P<0.05)。总有效率为72.23％(13
例)。急性放射性食管炎1、2 级发生率分别为61.1%、16.7%,急性放射性肺炎1、2 级发生率分别为77.8%、11.1%，骨髓抑制1、2、3
级分别为61.1%、22.2%、11.1%,急性心脏损伤1、2 级发生率分别为83.3%、16.7%。结论：RapidArc 联合呼吸门控在非小细胞肺癌
精确放疗中具有减少正常组织受照剂量体积和提高放疗精度的作用。 |
| 英文摘要: |
| Objective:To investigate the application of RapidArc combined respiratory gating technique in the radiotherapy of
non-small cell lung cancer.Methods:Nineteen inoperable Ⅲ A-Ⅲ B non-small cell lung cancer patients were selected under free
breathing (FB) and respiratory gating system (RC) stater espectively, four kinds of radiation treatment planning for each patient were
designed: under FB IMRT (IMRT-FB), double arc RapidArc (Arc-FB) and under RC IMRT (IMRT-RC), double arc RapidArc (Arc-RC).
The efficacy and side effects of four plans and Arc-RC were evaluated.Results:Except one patient dropped out due to economic reasons,
other patients were successfully treated.The average volume of PTV reduced from 296cm3 under the FB state to 210.2cm3 under the RC
state; The average volume of lung was 3817.4cm3 under the RC, an increase of 34% the FB;The CI, HI and D2%, D98%, V95 of Arc-RC
planning target volume, compared with IMRT-FB, Arc-FB, IMRT-RC plan had no significant difference, but V20, V30, V40, V50, and the
average dose (Dmean) of the lungs was significantly lower than the latter three (P<0.05). The total effective rate was 72.23%(13 cases).
The rates of acute radiation esophagitis 1,2-level were 61.1%, 16.7%; The rates of acute radiation pneumonitis 1,2-level were 77.8%,
11.1%; the rates of myelosuppression 1,2,3-level were 61.1%, 22.2%, 11.1%, and the rates of acute cardiac injury 1,2-level were 83.3%,
16.7%.Conclusion:RapidArc combined respiratory gating accurate in non-small cell lung cancer radiotherapy can reduce the volume of
normal tissue radiation dose and increasing the role of radiotherapy precision. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
